Akebia Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold AKBA, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
6
Funds holding
$6378906
Total value held
Flat
3 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Citigroup Inc | $3922287 | 2436203 | +519511 | +27.10% |
| 2 | Invesco Ltd. | $1077395 | 669190 | -1731567 | -72.13% |
| 3 | Bank Of New York Mellon Corp | $904682 | 650851 | -16056 | -2.41% |
| 4 | Wells Fargo & Company/Mn | $460082 | 285765 | +95676 | +50.33% |
| 5 | Ameriprise Financial Inc | $14443 | 10391 | -605 | -5.50% |
| 6 | Amalgamated Financial Corp. | $17 | 24241 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.